Skip to main content

Business Intelligence

By Jeff Lagasse | 12:03 pm | October 25, 2022
Merck joins drugmakers AstraZeneca, Novartis, Eli Lilly, Novo Nordisk and others singled out for potential fines.
By Jeff Lagasse | 03:45 pm | October 24, 2022
Orphan drugs are priced more than 30 times higher than non-orphan drugs, the UnitedHealth Group subsidiary says.
By Jeff Lagasse | 04:10 pm | October 21, 2022
Students are eligible to receive up to $7,000 per semester in tuition loan forgiveness for all remaining semesters.
By Susan Morse | 11:04 am | October 21, 2022
CVS Health says it anticipates the transaction closing in the first half of 2023.
By Jeff Lagasse | 12:02 pm | October 20, 2022
The insurer was ranked as the best overall Medicare Advantage company, the best for member experience and the best for low-premium plans.
By HIMSS TV | 06:00 am | October 20, 2022
<p>Philips is repurposing tech innovations it conceived during the emergence of the pandemic to help address healthcare access worldwide. The company's Vice President of U.S. Government Solutions Christina Nichols gives the details.</p>
By Jeff Lagasse | 03:43 pm | October 19, 2022
Revenues reached $39.9 billion, up 11.5% from the $35.8 billion in revenue posted a year ago.
By Jeff Lagasse | 11:54 am | October 19, 2022
The platform seeks to improve care equity and healthcare literacy and confidence, while reducing care avoidance.
By Susan Morse | 09:49 am | October 18, 2022
Humana, which has also reportedly shown interest, has the right of first refusal in a sale.
By Jeff Lagasse | 10:43 am | October 17, 2022
Other top headlines this past week include a look at how telemedicine can improve orthopedic care.